{"id":68863,"date":"2026-04-04T07:07:19","date_gmt":"2026-04-04T07:07:19","guid":{"rendered":"https:\/\/diyhaven858.wasmer.app\/index.php\/canaccord-lowers-niagen-bioscience-inc-nage-pt-on-updated-forecasts-following-q4-results\/"},"modified":"2026-04-04T07:07:19","modified_gmt":"2026-04-04T07:07:19","slug":"canaccord-lowers-niagen-bioscience-inc-nage-pt-on-updated-forecasts-following-q4-results","status":"publish","type":"post","link":"https:\/\/diyhaven858.wasmer.app\/index.php\/canaccord-lowers-niagen-bioscience-inc-nage-pt-on-updated-forecasts-following-q4-results\/","title":{"rendered":"Canaccord Lowers Niagen Bioscience, Inc. (NAGE) PT on Updated Forecasts Following Q4 Results"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<div>\n<p class=\"yf-1fy9kyt\"><!-- HTML_TAG_START -->We recently compiled a list of the <strong>12 Penny Stocks with Insider Buying in 2026<\/strong>. Niagen Bioscience, Inc. is one of the best stocks with insider buying<strong>.\u00a0<\/strong><!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1fy9kyt\"><!-- HTML_TAG_START -->TheFly reported on March 5 that Canaccord Genuity revised its price target for NAGE to $13, down from $14, while maintaining a Buy rating. The adjustment follows updated modeling after the company\u2019s Q4 results, which showed continued robust demand for its main product lines. The firm also highlighted potential growth opportunities in NAGE\u2019s injectable segment, noting that this area could contribute additional upside for the business.<!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1fy9kyt\"><!-- HTML_TAG_START -->Separately, on March 19, Niagen Bioscience, Inc. (NASDAQ:NAGE) announced that its board of directors approved an increase to the company\u2019s existing share repurchase program, doubling the total authorization from $10 million to $20 million of outstanding common stock.<!-- HTML_TAG_END --><\/p>\n<figure data-testid=\"article-figure-image\" class=\"yf-750ceo\">\n<div class=\"image-container yf-lglytj\" style=\"--max-height: 538px;\">\n<div class=\"image-wrapper yf-lglytj\" style=\"--aspect-ratio: 960 \/ 538; --img-max-width: 960px;\"><img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/s.yimg.com\/ny\/api\/res\/1.2\/d5.IW273mMxy0Gv2HgkR.A--\/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTUzOA--\/https:\/\/media.zenfs.com\/en\/insidermonkey.com\/45c4e3db1fd02e986b4a067353fde69e\" alt=\"Canaccord Lowers Niagen Bioscience, Inc. (NAGE) PT on Updated Forecasts Following Q4 Results\" loading=\"eager\" height=\"538\" width=\"960\" class=\"yf-lglytj  loaded\"\/><\/div>\n<\/div><figcaption class=\"yf-750ceo\"><!-- HTML_TAG_START -->Canaccord Lowers Niagen Bioscience, Inc. (NAGE) PT on Updated Forecasts Following Q4 Results<!-- HTML_TAG_END -->  <\/figcaption><\/figure>\n<p class=\"yf-1fy9kyt\"><!-- HTML_TAG_START -->As of March 17, the company had already repurchased roughly $2.6 million of its shares under this program. The expansion of the buyback authorization reflects the company\u2019s continued focus on returning capital to shareholders while providing additional flexibility to repurchase stock in the open market. The move positions NAGE to manage its capital structure proactively while supporting shareholder value.<!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1fy9kyt\"><!-- HTML_TAG_START -->Niagen Bioscience, Inc. (NASDAQ:NAGE) is a Los Angeles\u2013based bioscience company pioneering NAD\u207a research and healthy\u2011aging solutions, best known for its patented nicotinamide riboside ingredient powering Tru Niagen supplements and other NAD\u207a\u2011boosting products backed by scientific research.<!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1fy9kyt\"><!-- HTML_TAG_START -->While we acknowledge the potential of NAGE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you&#8217;re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the <b>best short-term AI stock<\/b>.<!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1fy9kyt\"><!-- HTML_TAG_START --><b>READ NEXT: <\/b><b>33 Stocks That Should Double in 3 Years<\/b><b> and <\/b><b>15 Stocks That Will Make You Rich in 10 Years<\/b><b>\u00a0<\/b><!-- HTML_TAG_END --><\/p>\n<p class=\"yf-1fy9kyt\"><!-- HTML_TAG_START -->Disclosure: None. <b>Follow Insider Monkey on Google News<\/b><b>.<\/b><!-- HTML_TAG_END --><\/p>\n<\/p><\/div>\n<p><br \/>\n<br \/><a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>We recently compiled a list of the 12 Penny Stocks with Insider Buying in 2026. Niagen Bioscience, Inc. is one of the best stocks with insider buying.\u00a0 TheFly reported on March 5 that Canaccord Genuity revised its price target for NAGE to $13, down from $14, while maintaining a Buy rating. The adjustment follows updated [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":68864,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_daextam_enable_autolinks":"","jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[10],"tags":[6415,6413,6414,565],"class_list":["post-68863","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business-news","tag-bioscience","tag-canaccord-genuity","tag-nage","tag-penny-stocks"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/diyhaven858.wasmer.app\/wp-content\/uploads\/2026\/04\/45c4e3db1fd02e986b4a067353fde69e.jpeg","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/posts\/68863","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/comments?post=68863"}],"version-history":[{"count":0,"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/posts\/68863\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/media\/68864"}],"wp:attachment":[{"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/media?parent=68863"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/categories?post=68863"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/diyhaven858.wasmer.app\/index.php\/wp-json\/wp\/v2\/tags?post=68863"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}